High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer

Mounting evidence indicates that vitamin C has the potential to be a potent anti-cancer agent when administered intravenously and in high doses (high-dose IVC). Early phase clinical trials have confirmed safety and indicated efficacy of IVC in eradicating tumour cells of various cancer types. In rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Böttger, Franziska, Vallés-Martí, Andrea, Cahn, Loraine, Jimenez, Connie R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557029/
https://www.ncbi.nlm.nih.gov/pubmed/34717701
http://dx.doi.org/10.1186/s13046-021-02134-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557029/
https://www.ncbi.nlm.nih.gov/pubmed/34717701
http://dx.doi.org/10.1186/s13046-021-02134-y

Ejemplares similares